dupilumab (Dupixent) Last Updated: October 23, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: dupilumab Indications: atopic dermatitis Brand Name: DupixentManufacturer: Sanofi Genzyme, a division of sanofi-aventis Canada Inc.Project Number: SR0636-000Project Status: ReceivedSubmission Type: New Details
telotristat (Xermelo) Last Updated: October 23, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: telotristat Indications: carcinoid syndrome Brand Name: XermeloManufacturer: Ipsen Biopharmaceuticals Canada Inc. Project Number: SR0580-000Project Status: CompleteSubmission Type: New Details
Brentuximab Vedotin (Adcetris) for Peripheral T-cell Lymphoma Last Updated: October 23, 2019 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10199 Details
Lynparza for Newly Diagnosed Ovarian Cancer – Details Last Updated: October 23, 2019 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10174 Details
siponimod (Mayzent) Last Updated: October 22, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: siponimod Indications: Secondary progressive multiple sclerosis Brand Name: MayzentManufacturer: Novartis Pharmaceuticals Canada Inc.Project Number: SR0631-000Project Status: ActiveSubmission Type: New Details
onabotulinumtoxinA (Botox) Last Updated: October 23, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: onabotulinumtoxinA Indications: Migraine, chronic Brand Name: BotoxManufacturer: Allergan Canada Inc.Project Number: SR0584-000Project Status: ActiveSubmission Type: Resubmission Details
dolutegravir / lamivudine (Dovato) Last Updated: October 23, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: dolutegravir / lamivudine Indications: HIV-1 infection Brand Name: DovatoManufacturer: ViiV HealthcareProject Number: SR0601-000Project Status: CompleteSubmission Type: New Details
fluocinolone acetonide intravitreal implant (Iluvien) Last Updated: October 22, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: fluocinolone acetonide intravitreal implant Indications: diabetic macular edema Brand Name: IluvienManufacturer: Knight Therapeutics Inc.Project Number: SR0608-000Project Status: CompleteSubmission Type: New Details
Entrectinib (TBD) for Neurotrophic Tyrosine Receptor Kinase (NTRK) Fusion-Positive Solid Tumours Last Updated: October 23, 2019 Result type: Reports Product Line: Pan Canadian Oncology Drug Review Project Number: pCODR 10157 Details
brolucizumab (TBC) Last Updated: October 22, 2019 Result type: Reports Product Line: Common Drug Review Generic Name: brolucizumab Indications: Macular degeneration, age-related Brand Name: TBCManufacturer: Novartis Pharmaceuticals Canada Inc.Project Number: SR0632-000Project Status: ReceivedSubmission Type: New Details
